Related Experiment Videos
Astaxanthin Inhibits ox-LDL-Induced Early Endothelial Progenitor Cells Oxidative Stress and Apoptosis Through Nrf2
Keqing Pan1, Xiao Xu1, Qijun Jiang1,2
1Wuhan University of Science and Technology School of Medicine Wuhan China.
Abstract:
Astaxanthin exerts potent protective effects against stem cell apoptosis. This study investigated the protective efficacy of astaxanthin against oxidized low-density lipoprotein (ox-LDL)-induced oxidative stress and apoptosis in endothelial progenitor cells (EPCs). Human early EPCs cultured in vitro were challenged with ox-LDL in the presence or absence of astaxanthin. Results showed that ox-LDL exposure significantly reduced nuclear factor-E2-related factor 2 (Nrf2) nuclear translocation in EPCs, while increasing oxidative stress and apoptosis rates. Astaxanthin pretreatment attenuated ox-LDL-induced reactive oxygen species (ROS) generation and EPC apoptosis, preserved mitochondrial membrane potential (MMP), and concomitantly enhanced nuclear Nrf2 accumulation while upregulating NQO1, HO-1, and glutathione (GSH) levels. Nrf2 small interfering RNA (siRNA)-mediated knockdown completely abolished astaxanthin-induced NQO1 and HO-1 upregulation. Mechanistically, astaxanthin promoted Akt phosphorylation (activation) and inhibited glycogen synthase kinase 3β (GSK-3β) phosphorylation. Pretreatment with LY294002 (a phosphoinositide 3-kinase/PI3K inhibitor) suppressed astaxanthin-induced Nrf2 nuclear translocation, exacerbated ROS production, and reduced NQO1 and GSH levels. Additionally, astaxanthin blocked ox-LDL-induced caspase-3 upregulation and preserved EPC migration and tube formation. Nrf2 siRNA eliminated the protective effects of astaxanthin on EPC ROS production, MMP preservation, apoptosis, and migration; tube formation was not assessed. Overall, these in vitro findings using cells from healthy donors provide mechanistic support for the potential role of astaxanthin in the PI3K/Akt/GSK-3/Nrf2 pathway. However, the application of astaxanthin in the prevention and treatment of atherosclerotic disease requires further validation in disease-relevant models and clinical studies, as the present study was limited to in vitro results.